Minimally invasive aortic valve replacement in morbidly obese patients: outcomes from a cohort study and pooled data analysis
Open Access
- 16 January 2026
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Cardiovascular Medicine
- Vol. 12, 1659991
Abstract
Background: In the context of cardiac surgery, morbid obesity poses several perioperative challenges. Some surgeons consider obesity a relative contraindication for minimally invasive aortic valve replacement (MIAVR) due to anatomical and technical complexities. Although MIAVR is increasingly used in standard-risk populations, evidence supporting its safety and efficacy in morbidly obese patients remains limited. Methods: This retrospective cohort consisted of 920 patients who underwent MIAVR via partial upper ministernotomy at a high-volume cardiac surgery center between 2010 and May 2025. Patients were categorized into three groups based on BMI: Class I obesity (BMI 30–35 kg/m 2 ; n = 164), Class II–III obesity (BMI > 35 kg/m 2 ; n = 54), and a non-obese control group ( n = 702). Key clinical outcomes, echocardiographic parameters, postoperative complications, and long-term mortality rates were compared. Additionally, a pairwise meta-analysis was conducted, incorporating five studies to assess outcomes of MIAVR vs. conventional full sternotomy in obese individuals. Results: There were no significant differences in most of postoperative outcomes. However, higher rates of pneumothorax and arrhythmias were observed in Class II–III obesity. Multivariate regression did not identify obesity as an independent predictor of adverse outcomes. Meta-analysis confirmed comparable operative times and a trend toward shorter ICU stays and lower respiratory complications in the MIAVR group. Conclusion: This study argues that (i) obesity alone should not delay, deter, or preclude appropriate candidates from being referred for surgical aortic valve replacement, and (ii) partial upper ministernotomy should be considered the preferred access route in obese patients, as it consistently facilitates recovery without compromising safety.Keywords
This publication has 33 references indexed in Scilit:
- Impact of Body Mass Index on the Initial Phase of a Minimally Invasive Aortic Valve ProgramThe Thoracic and Cardiovascular Surgeon, 2024
- Aortic valve function and aortic dimensions in obese and overweight patients with bicuspid aortic valveCardiology in the Young, 2024
- Outcomes of Surgical Versus Transcatheter Aortic Valve Replacement in Obese Patients: A Systematic Review and Meta-AnalysisCardiology in Review, 2024
- The Mortality Burden of Untreated Aortic StenosisJACC, 2023
- Association of body mass index with 30-day mortality and red blood cell transfusions in open heart surgeryEuropean Journal of Cardio-Thoracic Surgery, 2023
- Feasibility of transcaval access TAVI in morbidly obese patients: A single‐center experienceCatheterization and Cardiovascular Interventions, 2022
- Is the Obesity Paradox in Cardiac Surgery Really a Myth? Effect of Body Mass Index on Early and Late Clinical OutcomesJournal of Cardiothoracic and Vascular Anesthesia, 2021
- Is obesity associated with poorer outcomes in patients undergoing minimally invasive mitral valve surgery?European Journal of Cardio-Thoracic Surgery, 2020
- The epidemiology of obesityMetabolism, 2019
- Outcomes of aortic valve replacement via partial upper sternotomy versus conventional aortic valve replacement in obese patientsInteractive CardioVascular and Thoracic Surgery, 2018